Scandion Oncology A/S (STO:SCOL)
Sweden
· Delayed Price · Currency is SEK 0.0227
-0.0024 (-9.56%)
May 15, 2025, 5:23 PM CET
Scandion Oncology Market Cap
Scandion Oncology has a market cap or net worth of 5.89 million as of May 15, 2025. Its market cap has decreased by -89.59% in one year.
Market Cap
5.89M
Enterprise Value
-13.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since January 10, 2020, Scandion Oncology's market cap has decreased from 195.09M to 5.89M, a decrease of -96.98%. That is a compound annual growth rate of -48.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 4.55M | -73.64% |
| Dec 30, 2024 | 17.28M | -89.38% |
| Dec 29, 2023 | 162.62M | 42.68% |
| Dec 30, 2022 | 113.98M | -71.35% |
| Dec 30, 2021 | 397.84M | -37.63% |
| Dec 30, 2020 | 637.89M | 226.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.97B |
| Sectra AB | 59.23B |
| Getinge AB | 50.70B |
| Camurus AB | 39.14B |
| Medicover AB | 36.18B |
| AddLife AB | 22.95B |
| Vitrolife AB | 21.42B |
| Vimian Group AB | 20.64B |